Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cab54504be0eacd601e3693a407ddb52 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4439 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-437 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-437 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
filingDate |
2016-12-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bf5a22c7702eeb013c207b9f72a37cf8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ceee30631174f6ed8e273c58423b4a97 |
publicationDate |
2017-08-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2017128917-A1 |
titleOfInvention |
Parazole condensed-ring derivatives and preparation method thereof and application thereof in treatment of cancers, inflammation and immune diseases |
abstract |
The present invention relates to parazole condensed-ring derivatives and preparation method and medicinal application thereof Specifically, the present invention relates to new derivatives shown as the formula (I), medicinal salts thereof or medicinal compositions containing same, and preparation method therefor. The present invention further relates to applications of the derivatives and medicinal salts thereof or medicinal compositions containing the same in preparation of therapeutic agents, especially Bruton tyrosine kinase inhibitor and in preparation of medicines used for treating and/or preventing tumors and immunity-associated diseases. The substituents in formula (I) has the same definition as in description. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022048551-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023122600-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021089791-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020188015-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11155546-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11174254-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021148581-A1 |
priorityDate |
2016-01-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |